Cited 0 times in 
Cited 0 times in 
Additive renoprotective effects of oral calcitriol on patients with IgA nephropathy receiving RAS blockers
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Joo, Young Su | - |
| dc.contributor.author | Chang, Tae-Ik | - |
| dc.contributor.author | Kim, Dong Ki | - |
| dc.contributor.author | Han, Seung Hyeok | - |
| dc.contributor.author | Kang, Shin-Wook | - |
| dc.contributor.author | Yoo, Tae-Hyun | - |
| dc.date.accessioned | 2025-12-23T02:40:55Z | - |
| dc.date.available | 2025-12-23T02:40:55Z | - |
| dc.date.created | 2025-12-11 | - |
| dc.date.issued | 2025-11 | - |
| dc.identifier.issn | 0931-0509 | - |
| dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/209530 | - |
| dc.description.abstract | Background Patients with immunoglobulin A nephropathy (IgAN) and moderate proteinuria are at risk of progressive renal failure despite the maximal use of renin-angiotensin system blockers (RASBs). This study evaluated the efficacy of active vitamin D in reducing proteinuria in patients with IgAN receiving RASBs.Methods In this double-blind, placebo-controlled trial, we enrolled biopsy-confirmed patients with IgAN and persistent proteinuria (0.5-3.5 g/day) after maximal use of RASBs. Patients were randomized to receive either 0.25 mu g/day of calcitriol or placebo for 12 months. The primary outcomes were the change in the mean urinary protein:creatinine ratio (UPCR) and daily urinary protein excretion during the treatment.Results A total of 138 patients from six medical centres were enrolled and assigned to receive a placebo (n = 69) or 0.25 mu g of calcitriol (n = 69) and 115 patients (83.3%) completed the study. The calcitriol group showed a greater reduction in geometric means of UPCR {mean difference -187 mg/g [95% confidence interval (CI) -370.6 to -4.0], P = .04} and urinary albumin:creatinine ratio [-162 mg/g (95% CI -290.9 to -34.6), P = .01] than placebo. Changes in daily urinary protein excretion were -3.5% (from 1.32 to 1.02 g/day) in the control group and -13.1% (from 1.29 to 0.97 g/day) in the calcitriol group, without any statistically significant differences (P = .11). The annual decrease of the estimated glomerular filtration rate (eGFR) was -0.32 ml/min/1.73 m2 (95% CI -2.54 to 1.99) in the calcitriol group and -3.64 ml/min/1.73 m2 (95% CI -5.70 to -1.58) in the placebo group (calcitriol versus placebo over time, P = .02). Adverse events were comparable between the groups.Conclusion The addition of 0.25 mu g/day calcitriol to RASBs safely lowered residual proteinuria and slowed the eGFR decline in patients with IgAN, suggesting a potential therapeutic role for calcitriol in this population. | - |
| dc.language | English | - |
| dc.publisher | Oxford University Press | - |
| dc.relation.isPartOf | NEPHROLOGY DIALYSIS TRANSPLANTATION | - |
| dc.relation.isPartOf | NEPHROLOGY DIALYSIS TRANSPLANTATION | - |
| dc.title | Additive renoprotective effects of oral calcitriol on patients with IgA nephropathy receiving RAS blockers | - |
| dc.type | Article | - |
| dc.contributor.googleauthor | Joo, Young Su | - |
| dc.contributor.googleauthor | Chang, Tae-Ik | - |
| dc.contributor.googleauthor | Kim, Dong Ki | - |
| dc.contributor.googleauthor | Han, Seung Hyeok | - |
| dc.contributor.googleauthor | Kang, Shin-Wook | - |
| dc.contributor.googleauthor | Yoo, Tae-Hyun | - |
| dc.identifier.doi | 10.1093/ndt/gfaf187 | - |
| dc.relation.journalcode | J02316 | - |
| dc.identifier.eissn | 1460-2385 | - |
| dc.identifier.pmid | 41178795 | - |
| dc.identifier.url | https://academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfaf187/8251687 | - |
| dc.subject.keyword | calcitriol | - |
| dc.subject.keyword | IgA nephropathy | - |
| dc.subject.keyword | immunoglobulin A nephropathy | - |
| dc.subject.keyword | vitamin D | - |
| dc.contributor.affiliatedAuthor | Joo, Young Su | - |
| dc.contributor.affiliatedAuthor | Han, Seung Hyeok | - |
| dc.contributor.affiliatedAuthor | Kang, Shin-Wook | - |
| dc.contributor.affiliatedAuthor | Yoo, Tae-Hyun | - |
| dc.identifier.wosid | 001605979700001 | - |
| dc.identifier.bibliographicCitation | NEPHROLOGY DIALYSIS TRANSPLANTATION, 2025-11 | - |
| dc.identifier.rimsid | 90311 | - |
| dc.type.rims | ART | - |
| dc.description.journalClass | 1 | - |
| dc.description.journalClass | 1 | - |
| dc.subject.keywordAuthor | calcitriol | - |
| dc.subject.keywordAuthor | IgA nephropathy | - |
| dc.subject.keywordAuthor | immunoglobulin A nephropathy | - |
| dc.subject.keywordAuthor | vitamin D | - |
| dc.subject.keywordPlus | IMMUNOGLOBULIN-A NEPHROPATHY | - |
| dc.subject.keywordPlus | NATURAL-HISTORY | - |
| dc.subject.keywordPlus | RENAL SURVIVAL | - |
| dc.subject.keywordPlus | KIDNEY-DISEASE | - |
| dc.subject.keywordPlus | DOUBLE-BLIND | - |
| dc.subject.keywordPlus | PARICALCITOL | - |
| dc.subject.keywordPlus | ALBUMINURIA | - |
| dc.subject.keywordPlus | PROTEINURIA | - |
| dc.subject.keywordPlus | PREDICTION | - |
| dc.subject.keywordPlus | REDUCTION | - |
| dc.type.docType | Article; Early Access | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalWebOfScienceCategory | Transplantation | - |
| dc.relation.journalWebOfScienceCategory | Urology & Nephrology | - |
| dc.relation.journalResearchArea | Transplantation | - |
| dc.relation.journalResearchArea | Urology & Nephrology | - |
| dc.identifier.articleno | gfaf187 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.